A Concise Review of Organoid Tissue Engineering: Regenerative Applications and Precision Medicine

    July 2025 in “ Organoids
    Karnika Yogeswari Makesh, Abilash Navaneethan, Mrithika Ajay, Ganesh Munuswamy‐Ramanujam, Arulvasu Chinnasamy, Dhanavathy Gnanasampanthapandian, Kanagaraj Palaniyandi
    Studysummary This review summarizes the state of organoid technology, highlighting its potential to transform biomedical research and regenerative medicine by providing accurate models for disease study, drug discovery, and potentially developing functional organs for transplantation.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Organoid tissue engineering has emerged as a transformative tool in regenerative and precision medicine, offering advanced models for studying human diseases and developing personalized therapies. Organoids, derived from stem cells, mimic the architecture and function of real organs, providing a more accurate representation of human biology than traditional 2D cultures. They are particularly promising in cancer research, where patient-derived tumor organoids aid in drug screening and predicting treatment responses, facilitating tailored therapeutic strategies. Despite challenges like vascularization and maturity, advancements in technologies such as CRISPR-Cas9, microfluidics, and bioprinting enhance organoid research. These models are crucial for understanding diseases, drug discovery, and personalized medicine, although ethical considerations and standardization remain important issues to address.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results